title: Biologic and cytogenetic characteristics of leukemia in infants.
abstract: Clinical features, leukemic cell characterization, chromosomal findings, and treatment outcome were analyzed in a retrospective study of 30 cases with acute leukemia of infancy, 24 infants with acute lymphoblastic leukemia (ALL), and six cases with acute nonlymphoblastic leukemia (ANLL). Extensive bulky disease with organomegaly, central nervous system (CNS), and skin involvement were prominent features at diagnosis with a higher frequency in ANLL as compared to ALL. Four of six ANLL patients were classified as monocytic or myelomonocytic. In the ALL group nine of 24 (36%) were non-L1 morphology and six of 17 (33%) were common ALL antigen (CALLA) negative, the majority of them (five of six) were included in the non-L1 group. Immunophenotyping revealed four cases with early B-cell (three patients: Ia+B4+, and one patient: Ia+) and two cases with T-cell. Mixed lineage leukemia was found in five infants. Heavy chain immunoglobulin gene rearrangement was present in six cases tested, two CALLA+, two with Ia+B4+, and two were undifferentiated mixed lineage leukemia. Chromosomal aberrations were detected in ten of 18 patients, mostly in ANLL and CALLA negative ALL. Translocations were detected in six patients, involving 4q21-23 and 11q23 in three and two cases, respectively. The probability of five-year DFS were 27% for the whole group. The worst prognosis was observed in infants younger than 6 months of age, in whom the leukemia cell characteristics was compatible with stem cell: ANLL, very early pre-B, or undifferentiated mixed type. The chromosomal aberrations found in all cases included translocation with the seemingly nonrandom breakpoints at 4q21 and 11q23, and breakpoints that corresponded to known fragile sites. This finding may be suggestive of an underlying genetic predisposition associated with the poor prognosis of leukemia of infancy.
authors.affiliation: Sambur Center for Pediatric Hematology Oncology, Beilinson Medical Center, Petach Tikvah, Israel.
authors.forename: B
authors.initials: B
authors.lastname: Stark
authors.forename: R
authors.initials: R
authors.lastname: Vogel
authors.forename: I J
authors.initials: IJ
authors.lastname: Cohen
authors.forename: T
authors.initials: T
authors.lastname: Umiel
authors.forename: Z
authors.initials: Z
authors.lastname: Mammon
authors.forename: G
authors.initials: G
authors.lastname: Rechavi
authors.forename: C
authors.initials: C
authors.lastname: Kaplinsky
authors.forename: D
authors.initials: D
authors.lastname: Potaznik
authors.forename: A
authors.initials: A
authors.lastname: Dvir
authors.forename: Y
authors.initials: Y
authors.lastname: Yaniv
mesh_terms: D005260:Female; D006801:Humans; D007223:Infant; D007585:Jews; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D008297:Male; D010641:Phenotype; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D011379:Prognosis; D012074:Remission Induction; D012189:Retrospective Studies